Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications

This publication has 34 references indexed in Scilit:

• The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
  Journal of Clinical Investigation, 1988
• cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell
  FEBS Letters, 1987
• The biology of platelet-derived growth factor
  Cell, 1986
• Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.
  The Journal of cell biology, 1986
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
  Journal of Clinical Investigation, 1983
• The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production
  Journal of Immunological Methods, 1982
• “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
  Analytical Biochemistry, 1981
• Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface Antigen
  Science, 1980
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970